证券记录 · 已归档季度
WGS
GeneDx Holdings Corp. · Healthcare · Medical - Diagnostics & Research
13被追踪持有人
+1Δ持有人
1.90M持有股份
$146.41M报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +8.3% ·
股份流向 -5.3% ·
净新建仓位 +7.7%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 88 | -5 | 15.43M | $1.06B | +10 | −14 |
| Q1 2026 | 95 | +2 | 15.21M | $977.50M | +14 | −13 |
| Q4 2025 | 94 | +1 | 15.07M | $1.96B | +3 | −1 |
| Q3 2025 | 16 | -1 | 7.41M | $798.15M | +2 | −4 |
| Q2 2025 | 15 | -1 | 4.67M | $430.80M | +1 | −2 |
| Q1 2025 | 13 | 0 | 2.11M | $186.46M | — | — |
| Q4 2024 | 13 | +1 | 1.90M | $146.41M | +2 | −1 |
| Q3 2024 | 11 | +4 | 1.69M | $71.81M | +4 | — |
| Q2 2024 | 7 | — | 992.14K | $25.94M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 382.35K | +1.2% | $29.40M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 382.35K | +1.2% | $29.40M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (被动) | 319.91K | — | $24.59M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 294.52K | +838.2% | $22.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 294.52K | +838.2% | $22.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 205.12K | +119.2% | $15.77M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 152.07K | +276.3% | $11.69M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 140.79K | 新增 | $10.82M | 0.0% | New | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 140.79K | 新增 | $10.82M | 0.0% | New | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 140.79K | 新增 | $10.82M | 0.0% | New | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 79.09K | +165.4% | $6.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 79.09K | +165.4% | $6.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Norges Bank ✦ (被动) | 68.00K | 新增 | $5.23M | 0.0% | New | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 66.97K | +5.3% | $5.15M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 66.97K | +5.3% | $5.15M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 63.09K | -78.5% | $4.85M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Millennium Management ✦ | 58.80K | -89.8% | $4.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 57.53K | -34.2% | $4.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 57.53K | -34.2% | $4.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 57.53K | -34.2% | $4.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 16.59K | +23.1% | $1.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Wellington Management | $10.82M | 0.0% |
| Wellington Management | $10.82M | 0.0% |
| Wellington Management | $10.82M | 0.0% |
| Norges Bank | $5.23M | 0.0% |
已清仓
| Marshall Wace | $3.67M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 28.70K 股份, $1,843 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据